Purpose: To propose a large coverage black-bright blood interleaved imaging sequence (LaBBI) for 3D dynamic contrastenhanced MRI (DCE-MRI) of the vessel wall. Methods: LaBBI consists of a 3D black-blood stack-of-stars golden angle radial acquisition with high spatial resolution for vessel wall imaging and a 2D bright-blood Cartesian acquisition with high temporal resolution for arterial input function estimation. The two acquisitions were performed in an interleaved fashion within a single scan. Simulations, phantom experiments, and in vivo tests in three patients were performed to investigate the feasibility and performance of the proposed LaBBI. Results: In simulation tests, the estimated K trans and v p by LaBBI were more accurate than conventional bright-blood DCE-MRI with lower root mean square error in all the tested conditions. In phantom test, no signal interference was found on the 2D scan in LaBBI. Pharmacokinetic analysis of the patients' data acquired by LaBBI showed that K trans was higher in fibrous tissue (0.0717 6 0.0279 min À1 ), while lower in necrotic core (0.0206 6 0.0040 min
INTRODUCTION
Vessel wall inflammation plays an important role in the development of vascular diseases such as atherosclerosis and aneurysms (1, 2) . In several studies, vessel wall inflammation has been shown to be associated with clinical vascular events (3, 4) . Thus, it is important to image vessel wall inflammation in vivo. Dynamic contrast-enhanced MRI (DCE-MRI) is a useful tool to analyze inflammation in carotid atherosclerosis noninvasively (5-10) by using pharmacokinetic modeling.
However, using DCE-MRI to evaluate inflammation in the vessel wall is technically challenging, especially in early lesions. There are two competing requirements in DCE data acquisition (11) : high temporal resolution brightblood imaging for arterial input function (AIF) acquisition and high spatial resolution black-blood imaging for vessel wall depiction. Currently, most studies have made compromises by acquiring only bright-blood images (6, 7, 10, 12, 13) for advanced plaques. The bright-blood technique can estimate the AIF directly, but the temporal resolution ($15 s) is compromised by the high spatial resolution required for vessel wall imaging and is usually insufficient to extract AIF accurately. More importantly, thin vessel walls with early lesions cannot be quantified reliably due to signal contamination from the luminal signal. Black-blood DCE techniques have also been proposed for vessel wall imaging (9, 14) that allow accurate thin vessel wall imaging by suppressing blood signal. However, AIF cannot be extracted directly from the black-blood images and may introduce bias in the pharmacokinetic analysis using the reference region method or population AIF (9, 14) .
Recently, several techniques enabling interleaved blackbright blood imaging have been introduced (15) (16) (17) , which can acquire bright-blood images for AIF and black-blood images for vessel wall in a single scan. However, these techniques are based on a double inversion recovery (18) or quadruple inversion recovery (19) prepulse for black-blood imaging. Thus, they are limited to 2D vessel wall imaging and with limited longitudinal coverage. Mendes et al. (20) proposed an interleaved 2D/3D bright-blood imaging sequence to perform 3D vessel wall DCE-MRI. However, the vessel wall imaging in this sequence may still suffer from luminal signal contamination, since no black-blood prepulse was used.
In this study, we propose a large coverage black-bright blood interleaved imaging sequence (LaBBI) for vessel wall DCE-MRI. In this sequence, the 3D large coverage high spatial resolution black-blood vessel wall images and 2D high temporal resolution bright-blood images can be acquired in an interleaved fashion within a single scan. In LaBBI, the spatial and temporal resolution of the two acquisitions can be adjusted flexibly to satisfy the requirements of pharmacokinetic analysis on different targets. Simulations, phantom studies, and in vivo experiments were performed to test the feasibility of the proposed LaBBI method.
METHODS

Sequence Design
LaBBI is composed of a 2D high temporal resolution brightblood imaging module and a 3D high spatial resolution black-blood imaging module (Fig. 1a) . For the 3D blackblood imaging module, the stack-of-stars (SoS) golden radial acquisition (21) was used, which performed Cartesian sampling in the slice (kz) direction with low-high acquisition order and radial sampling in the kx-ky plane. As shown in Figure 1a , each 3D shot consisted of the improved motion sensitized driven equilibrium (iMSDE) black-blood prepulse (22) for large coverage 3D blood signal suppression and spectral presaturation with inversion recovery (SPIR) fat suppression and data acquisition, where the radial spokes with the same angle through all slices were acquired. The 3D imaging slab was centered at the target vessel wall lesion (Fig. 1c) . For bright-blood imaging, 2D fast field echo Cartesian data acquisition was used, and the 2D imaging slice was positioned perpendicular to a large vessel adjacent to the vessel wall lesion (Fig. 1c) . In the 2D acquisition, a spatial saturation band was placed upstream of the 2D imaging slice (Fig. 1c) and performed in each repetition time (Fig. 1a) . The saturation band was used to induce the saturation recovery of blood signal and then eliminate the interference from the nonselective black-blood prepulse. The proposed sequence supports instantaneous switching (23) between brightand black-blood imaging modules. In our design, one brightblood imaging dynamic is interleaved with one 3D imaging block containing the user-defined number of 3D shots of black-blood imaging (Fig. 1a,b) .
Image Reconstruction
For the SoS golden angle radial data, the gradient delays in radial sampling was firstly compensated using the method in (24). The radial data was then reconstructed into time series by grouping several blocks of 3D imaging into temporal frames using an established reconstruction method (21) , which uses parallel imaging and compressed sensing together to reduce undersampling artifacts. The reconstruction equation is as follows:
where m is the image series to be reconstructed, d is the acquired multicoil data, S represents the coil sensitivity maps, F is the nonuniform fast Fourier transform (NUFFT) operator, TV t is the temporal total-variation operator, and k is the regularization factor. The coil sensitivities were obtained by NUFFT of all radial lines, and k was selected empirically (21) .
Imaging Parameters
All imaging experiments in this study were performed on a 3.0T Philips MR scanner (Achieva TX, Best, the Netherlands). The imaging parameters of LaBBI are shown in Table 1 . For the 3D vessel wall imaging module, 15 transverse slices were acquired with a large coverage of 30 mm. As such, the turbo field echo factor of the 3D shot was 15, which means that only 15 spokes (duration, $180 ms) were acquired after each iMSDE and SPIR prepulse so that the black-blood contrast and fat suppression could be maintained. Each 3D imaging block was set to contain three dummy shots and 10 acquisition shots, with the dummy shots restoring the steady state of the 3D acquisition. The signal evolutions of the 3D imaging during contrast passage with and without dummy shots are demonstrated in Supporting Figure S1 . In LaBBI, one 2D dynamic was interleaved with one 3D block, resulting in a temporal resolution of AIF, T aif ¼ 4.7 s. Two 3D blocks with 20 radial spokes per slice were used to reconstruct one frame of the 3D blackblood dynamic image series, resulting in a temporal resolution of vessel wall, T VW ¼ 9.4 s. The distance between the two imaging modules was about 20 mm.
Simulation Test
Simulations were performed to investigate the accuracy of pharmacokinetic parameters estimated by LaBBI. The traditional bright-blood DCE imaging sequence (6) was also simulated as a comparison. Both LaBBI and the traditional bright-blood DCE-MRI used the same 2D Cartesian acquisition for AIF, so the AIF C p was simulated directly using a biexponential equation (25) . The contrast agent concentration in the blood was calculated as
with an assumed hematocrit (Hct) value of 0.4 (25) . The changing T 1 values of blood after contrast injection can be calculated by:
where r1 ¼ 4.5 L/mmol/s (26), C[Gd] is the concentration of contrast agent, and T 10 is the precontrast T 1 value. In this study, T 10 was assumed to be 1650 ms for blood (27) . Then, signal curve of blood (Sig b ) can be calculated using the saturation recovery (SR) equation
where M 0b is the proton density of blood, t d is the saturation delay time, and a is the flip angle. Subsequently, the blood signal curves of the traditional bright-blood DCE (6) With known C p and given K trans , v p values, the uptake curves of the vessel wall (C t (t)) can be generated using the Patlak model (28):
And the changing T 1 values of vessel wall during dynamic imaging can be calculated using Equation [3] with an assumed T 10 of 1150 ms (17) . The simulated spheres were analytic in the Fourier domain (29) , which can be calculated using the corresponding acquisition trajectory and image signal. For traditional bright-blood DCE, Cartesian trajectory was simulated with a temporal resolution of 15 s (6). The signal curve of the vessel wall (Sig VW_traditional ) can be generated based on the spoiled gradient echo equation
where M 0VW is the proton density of the vessel wall, E 1; traditional ¼ expðÀTR traditional =T 1 Þ, TR traditional is the repetition time, and u is the flip angle. For the 3D vessel wall imaging module in LaBBI, the SoS golden angle radial trajectory was simulated using the parameters given in Table  1 , and the signal of each spoke was generated using Bloch simulation with the iMSDE prepulse represented by a
3 ms is the duration of iMSDE. The changing T 2 values during dynamic imaging were estimated by [7] where r2 ¼ 5.09 L/mmol/s (26) and T 20 was assumed to be 54 ms for vessel wall (30) . For each simulation, the zero-mean Gaussian noise was added to the simulated k-space. Then dynamic image frames were reconstructed from the simulated k-space data using Fourier transform for the Cartesian data and the reconstruction method described above for the SoS golden angle radial data. For pharmacokinetic analysis of the simulations, AIF was obtained by converting the generated signal curve to concentration curve using Equations [2] [3] [4] . For the traditional bright-blood DCE-MRI, pharmacokinetic analysis was performed based on Equations [3] , [5] , and [6] . For LaBBI, the steady state signal equation is (the derivation of the steady state equation is detailed in the Supporting Information)
where K is the total number of acquired slices. Combing Equations [3] , [5] , [7] , and [8] , K trans and v p can be estimated using the Levenberg-Marquardt curve fit. The K trans and v p maps were generated for both methods.
Each simulation was repeated 100 times with independent zero-mean Gaussian noise added. The mean value of each simulated sphere was calculated at every simulation. The estimation accuracy of the pharmacokinetic parameters was evaluated by the normalized root mean
, where P e and P t are the estimated mean values and simulated true values, N is the number of repeated simulations. The average and SD of the 100 repeats were also reported for the three simulation types.
Phantom Study
In this study, phantom scans were performed to test whether there was interference on the 2D bright-blood imaging from the iMSDE prepulse in the black-blood imaging module. A series of tubes with varied concentrations of gadolinium contrast agent were used to simulate the T 1 (300-1600 ms) before and after contrast injection. The phantom was set upright, and the two scan slabs in LaBBI were both performed coronally with a distance of about 20 mm. For the 2D imaging module, to induce the saturation recovery of signal, a slice-selective SR prepulse at the imaging location was used to simulate the saturation band. All other imaging parameters were the same to the in vivo experiments shown in Table 1 . The 3D imaging and 2D imaging modules were first performed in an interleaved fashion (LaBBI scan), and then performed separately with the same imaging settings. The agreement of the 2D images acquired by the interleaved and separate scan was investigated by comparing the acquired signal intensities of different tubes using Pearson correlation.
In Vivo Experiments
This study was approved by the institutional review board, and written informed consent was obtained from all participating subjects. Three male patients (age 70, 72, and 47 y for case 1, case 2 and case 3) with carotid artery atherosclerosis were scanned with a custom designed 36-channel neurovascular coil (31) . A 3D iMSDE-prepared turbo field echo black-blood sequence, 3D MERGE (32), was first sequence to identify the lesion location with a field of view ¼ 250 Â 160 Â 40 mm 3 , voxel size ¼ 0.8 Â 0.8 Â 0.8 mm 3 , and 50 coronal slices. The simultaneous noncontrast angiography and intraplaque hemorrhage (IPH) imaging sequence, SNAP (33), with the same field of view and voxel size as 3D MERGE, was also performed. Then, the LaBBI sequence was used to acquire DCE-MRI images with 3D imaging centered at the location with the largest lesion size. Coincident with the third dynamic of the bright-blood imaging, a bolus of 0.1 mmol/kg Gd-DTPA (Magnevist; Bayer Schering Pharma, Berlin, Germany) was intravenously injected at a rate of 1.5 mL/s, followed by a 20 mL saline flush at the same rate. The imaging parameters of LaBBI are shown in Table 1 . For two patients with obvious plaque, the postcontrast images were also acquired by a T1-weighted (T1W) inversion recovery prepared turbo field echo sequence, with an inversion delay time ¼ 500 ms, and voxel size ¼ 0.8 Â 0.8 Â 0.8 mm 3 .
In Vivo Image Analysis
On the 2D bright-blood images of LaBBI, a small region of interest was placed around the center of carotid artery lumen, and then a clustering algorithm was used to select voxels with strong enhancement to calculate the signal curve of blood to reduce the influence of inflow artifacts (7) . By assuming the T 10 ¼ 1650 ms (27) and Hct ¼ 0.4 (25) for blood, the AIF can be acquired using Equations [2] [3] [4] . The 3D SoS golden angle radial data was reconstructed into a dynamic series using Equation [1] with 20 spokes for each slice per frame. The 3D MERGE and SNAP images were reformatted to 2 mm axial slices according to the imaging geometry of LaBBI for analysis. Then, for case 1 and case 2, seven slices centered at bifurcation were selected from each carotid artery. For case 3, the imaging was targeted at intracranial internal carotid artery with location much higher than the bifurcation, so five slices covering artery were selected for each carotid artery.
The ability of the black-blood image of LaBBI to depict vessel wall was evaluated by comparing with 3D MERGE. The frame of LaBBI vessel wall images that visually best depicted vessel wall was selected by one reviewer. Then another experienced reviewer blinded to the image types drew the contours of lumen, outer wall, and muscle on the selected slices of LaBBI vessel wall and 3D MERGE using a custom-designed image analysis software (34) . The vessel wall area and maximum wall thickness (MWT) were compared between LaBBI and 3D MERGE using the Wilcoxon signed rank test and intraclass correlation coefficient.
For pharmacokinetic analysis, the regions of necrotic core (NC), calcification and IPH were also identified for slices with plaque, with NC and calcification defined on the postcontrast phase of LaBBI vessel wall images with postcontrast T1W and SNAP images as reference (35, 36) and IPH defined on SNAP images (33) . After registration of the LaBBI vessel wall series (37), the contours of lumen, outer wall, NC, and calcification defined on one frame of LaBBI vessel wall images with best vessel wall contrast were propagated to other frames. The reformatted SNAP images were registered to the LaBBI vessel wall images, and the IPH contours were mapped to LaBBI. The remaining regions in the plaque were assumed to be fibrous tissue (FT) (37) . The signals of LaBBI vessel wall images in the defined contour were then averaged to generate the uptake curves. Then, as performed in the simulation, based on Equations [3] , [5] , [7] , and [8] and assumed T 10 , T 20 , the mean K trans and v p can be estimated for the region of interest in each slice. No IPH was observed in the analyzed NC, and precontrast T 1 of NC, FT, and normal vessel wall, muscle was assumed to be 1150 ms (17) . For IPH, T 10 was set to be 500 ms (33, 38) . The precontrast T 2 values of normal vessel wall, muscle, FT, NC, and IPH reported by Biasiolli et al. (30) were used in the analysis, as shown in Table  2 . The calcification was excluded from analysis due to the lack of precontrast T 1 and T 2 .
The SNRs of blood and normal vessel wall were also estimated for the in vivo data. Signal was determined by the mean signal of all the dynamics in the corresponding region of interest, while noise was defined as the standard deviation of the mean signal in a peripheral air region in the same frames.
RESULTS
Simulation and Phantom Studies
In simulation of different K trans from 0.02 to 0.2 min À1 , fixed v p ¼ 0.05 and fixed K trans ¼ 0.1 min À1 , different v p from 0.01 to 0.1, the average K trans and v p maps of the 100 repeated simulations with vessel wall SNR ¼ 30, derived from LaBBI are shown in Fig. 2a,d and Fig. 3a,d . LaBBI tended to slightly underestimate the K trans and v p values, whereas the bright-blood DCE overestimated the parameters. However, the mean K trans and v p values estimated by LaBBI were consistently closer to the true values, with much smaller RMSE than the bright-blood DCE (Fig.  2b,c,e,f and Fig. 3b,c,e,f) . For the fixed K trans , the v p values had little influence on its estimation accuracy in LaBBI, whereas the estimation error of K trans tended to be lower at larger v p values in bright-blood DCE (Fig. 2e,f) . For the fixed v p , its estimation accuracy was higher at smaller K trans values in both LaBBI and bright-blood DCE (Fig. 3b,c) .
Simulation results of different SNR levels, with Figure 4 . An example of the average K trans and v p maps of the 100 repeated simulations of LaBBI at SNR ¼ 30 of vessel wall are shown in Figure 4a ,d. Higher SNR increased estimation accuracy in both LaBBI and bright-blood DCE methods. However, LaBBI was consistently better than traditional bright-blood DCE in K trans and v p estimations for all the tested SNR levels (Fig. 4b,c,e,f) , with smaller bias and much lower RMSEs (5%-8% versus 6%-13% for K trans ; 5%-8% versus 19%-23% for v p ). For the phantom study, signal intensity acquired by the 2D SR imaging module in the interleaved acquisition, imitating the LaBBI 2D AIF imaging module, agreed well with that of a separate acquisition (Fig. 5, R ¼ 0.99) , suggesting that the 3D black-blood prepulse had little influence on the saturation recovery signal.
In Vivo Experiments
All three subjects were imaged successfully. For comparison of LaBBI vessel wall images with 3D MERGE images, a total of 38 slices from the six carotid arteries were measured. The vessel wall area and MWT as measured with LaBBI were (mean 6 SD) 38.66 6 22.23 mm Among the 38 slices, plaque (focal wall thickness > 2 mm) was detected in 21 slices in four carotid arteries, among which one plaque had NC (case 1) and one plaque had IPH (case 2). For case 1, four high spatial resolution dynamic images of a representative slice with carotid plaque and an example slice of the normal vessel wall acquired using the 3D black-blood imaging module in LaBBI are demonstrated (Fig. 6a,b) . Blood suppression was sufficient before and after contrast in both the diseased and healthy locations. For comparison, the reformatted iMSDE and postcontrast T1W images are also shown in Figure 6a ,b. The locations with and without plaque can be clearly confirmed and an NC was identified in the diseased slice. High temporal resolution bright-blood dynamic images acquired by the 2D imaging module of LaBBI during contrast agent injection were also demonstrated (Fig. 6c) . For case 2, dynamic blackblood images of the two slices with IPH and bright-blood images acquired using LaBBI throughout the contrast injection process are shown in Figure 7 . The IPH regions were identified on the SNAP images (Fig. 7a) . For the LaBBI vessel wall images, good blood suppression could be seen for all frames. The LaBBI images of case 3 are shown in Supporting Figure S2 . For pharmacokinetic analysis, one example of the extracted AIF from the bright-blood images in LaBBI is shown in Figure 8 . The average K trans and v p of the measured slices for normal vessel wall, FT, NC, IPH, and muscle are summarized in Table 2 . Similar K trans and v p values were observed for the normal vessel wall and the muscle tissue. Compared with the normal vessel wall, NC and IPH had lower K trans and v p , whereas FT showed higher values. The measured SNR of blood in the brightblood images of the three cases was 63.4 6 3.8, and the SNR of the normal vessel wall was 33.5 6 3.1.
DISCUSSION
In this study, a large coverage black-bright blood interleaved imaging sequence, LaBBI, was proposed for vessel wall DCE-MRI. The proposed sequence could acquire both high temporal resolution bright-blood images and 3D large coverage high spatial resolution black-blood vessel wall images simultaneously. Simulations, phantom studies, and in vivo experiments were performed to demonstrate the feasibility and advantages of LaBBI.
The LaBBI sequence was designed to solve the technical problems in vessel wall DCE-MRI. For the vessel wall, the imaging target is small, especially in early lesions, and a submillimeter in-plane spatial resolution (such as 0.6 Â 0.6 mm 2 ) is usually needed (9, 10, 14, 17) . The vessel wall lesion may have a large distribution along the diseased artery. Sufficient imaging coverage is important to cover the whole plaque. Vessel wall signal may also be contaminated by luminal blood signal, especially after bolus arrival, making imaging of early lesions or the region near lumen in advanced plaques difficult. Therefore, blood signal should be suppressed in vessel wall DCE imaging (9, 14, 17) . In contrast, for AIF acquisition, the blood should not be suppressed, and high temporal resolution is required for accurate pharmacokinetic analysis of DCE data (11) . However, high spatial resolution or large coverage is not needed, because AIF can be acquired from one slice of large vessels. In a LaBBI scan, a 2D high temporal resolution bright-blood acquisition was interleaved with a 3D large coverage high spatial resolution black-blood acquisition, meeting the different technical requirements of vessel wall imaging and AIF acquisition in vessel wall DCE-MRI.
In the 3D imaging module of LaBBI, a black-blood prepulse iMSDE (22) was used. Compared with double inversion recovery (18) or quadruple inversion recovery (19) prepulse, iMSDE has the advantage of large coverage blood suppression, which enables large coverage 3D black-blood imaging in LaBBI. The iMSDE prepulse will introduce T 2 weighting into the vessel wall images. Unlike the traditional DCE analysis method, the T 2 effect should be considered in the conversion from image signal to contrast concentration, as was done in the simulations and in vivo experiments.
In addition, the 3D imaging module for LaBBI used the SoS golden-angle radial trajectory for acquisition. Using a parallel imaging and compressed sensing combination reconstruction method (21) , both high in-plane spatial resolution (0.6 Â 0.6 mm 2 ) and large coverage (30 m) of the vessel wall imaging were achieved with a temporal resolution of 4.7 s for AIF and 9.4 s for the vessel wall. However, compared with traditional Cartesian acquisitions (6), the reconstructed images from the SoS goldenangle radial data may have undersampling artifacts, which may introduce bias into the pharmacokinetic modeling. To address these concerns, simulation experiments considering the interleaved acquisition, T 2 effects of iMSDE, SoS golden-angle radial sampling, and reconstruction were performed. The results showed that the proposed LaBBI sequence had a consistently lower RMSE of estimated kinetic parameters than the conventional bright-blood DCE protocol (6) under all tested conditions. Notably, the simulation experiments did not consider vessel wall signal contamination from lumen in bright-blood DCE, which could further introduce bias into its pharmacokinetic modeling. Therefore, LaBBI, with the ability to acquire high temporal resolution AIF and large coverage high spatial resolution black-blood vessel wall images, has unique advantages for vessel wall DCE-MRI.
A common issue in interleaved black-bright imaging techniques is the difficulty in eliminating the interference of black-blood imaging on the AIF acquisition (15) (16) (17) 20) . In the proposed LaBBI sequence, the nonselective black-blood imaging pulses, iMSDE, will influence the blood signal and disturb the AIF acquisition. Therefore, a spatial saturation band was used and placed upstream of the 2D imaging slice, eliminating possible interference by inducing saturation recovery of the blood signal. In the phantom test, good agreement of the signal intensities of the 2D SR images acquired by the separate and interleaved scans proved that the interference from iMSDE was successfully eliminated.
In this study, the feasibility of LaBBI was demonstrated on three subjects with carotid atherosclerosis. LaBBI has been shown to successfully evaluate normal thin vessel walls, slightly thickened vessel walls, and vessel walls with advanced plaque containing necrotic cores and IPH, with sufficient blood suppression in both pre-and postcontrast images. Furthermore, the LaBBI vessel wall images can be used to depict vessel wall with good agreement of plaque burden measurements with 3D MERGE. For pharmacokinetic analysis, the normal vessel wall had similar K trans and v p values to muscle, in agreement with published work (39) . The fibrous tissue, which usually had active inflammation or enriched neovasculature (6), showed higher K trans and v p values, whereas the necrotic core and IPH, where little contrast agent uptake occurred, had low K trans and v p values, which echoed the findings of previous studies (37) .
Notably, the proposed interleaved acquisition scheme of LaBBI is also flexible for different applications and adjustable for practical imaging demands. For example, to further improve the temporal resolution of AIF, the interleaved scheme can be adjusted by reducing the number of 3D shots between the 2D imaging dynamics, or the spatial resolution of 2D imaging can be decreased when imaging large vessels. To further enlarge the acquisition coverage of LaBBI for intracranial or femoral artery imaging, the 3D imaging orientation can be changed to a coronal or sagittal orientation with proper adjustment to avoid placing the 2D imaging slice and the spatial saturation band on the targeted vessel wall lesion. Furthermore, the 3D imaging module for LaBBI can also be adjusted to acquire 3D isotropic images for curved arteries, such as the intracranial arteries.
There are several limitations in this study. First, the in vivo experiments lacked histological validation due to the unavailability of histological specimens. However, LaBBI is theoretically similar to the previously histologically validated DCE methods (6, 7) . Furthermore, the simulation studies demonstrated that LaBBI should have more accurate quantifications than the conventional method benefiting from the higher temporal resolution. Therefore, LaBBI should be able to quantify neovasculature and inflammation of the vessel wall in a way similar to that described in previously validated work. Second, the assumed precontrast T 1 and T 2 values were used in the pharmacokinetic analysis of LaBBI. Despite the possible bias introduced by the assumed precontrast T 1 and T 2 values, the pharmacokinetic analysis results of the in vivo data had findings similar to those of previously published work (17, 37, 39) with regard to normal vessel wall, fibrous tissue, NC, and IPH, suggesting the feasibility of LaBBI to characterize perfusion properties of vessel wall lesion. However, in future studies, it will be necessary to add precontrast T 1 , T 2 quantification (30, 40, 41) in vessel wall DCE-MRI. Furthermore, the proposed sequence should be investigated further with a larger study population.
In conclusion, the proposed LaBBI sequence for DCE-MRI of vessel wall has the ability to acquire 2D high temporal resolution bright-blood images and 3D large coverage high spatial resolution black-blood vessel wall images simultaneously. The results of simulation, phantom, and in vivo experiments suggest that LaBBI is accurate in pharmacokinetic modeling and feasible for in vivo vessel wall imaging. Therefore, the LaBBI sequence may be a better tool for the characterization of vessel wall perfusion.
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